Filings & corporate actions
- 12 NovresultsResults · Q2 FY27 · standalone-3.2%NSE
- 12 OctshareholdingShareholding · 30 Sept 2026-1.4%NSE
- 6 AugresultsResults · Q1 FY27 · standalone+5.4%NSE
- 30 JuldividendDividend · ₹5.00 per share+0.2%
- 18 JulshareholdingShareholding · 30 Jun 2026-0.3%NSE
- 13 MayresultsResults · Q4 FY26 · standalone-8.2%NSE
- 20 AprshareholdingShareholding · 31 Mar 2026-0.3%NSE
- 11 FebresultsResults · Q3 FY26 · standalone+3.7%NSE
- 17 JanshareholdingShareholding · 31 Dec 2025-2.3%NSE
Reaction to results · all yearsrose on day 0 in 12 of 42 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 12 Nov 2026 | -3.2% | -7.3% | — | 2.7× |
| Q1 FY27 | 6 Aug 2026 | +5.4% | +15.8% | +25.6% | 8.9× |
| Q4 FY26 | 13 May 2026 | -8.2% | -9.3% | -11.0% | 3.8× |
| Q3 FY26 | 11 Feb 2026 | +3.7% | +1.0% | -5.6% | 13.2× |
| Q2 FY26 | 13 Nov 2025 | -6.3% | -9.0% | -12.7% | 3.4× |
| Q1 FY26 | 2 Aug 2025 | -4.4% | -7.9% | -8.8% | 4.7× |
| Q4 FY25 | 16 May 2025 | -0.2% | -1.9% | +4.4% | 0.8× |
| Q3 FY25 | 12 Feb 2025 | -18.2% | -18.2% | -28.0% | 16.5× |
| Q2 FY25 | 14 Nov 2024 | -3.0% | -3.8% | +4.5% | 1.0× |
| Q1 FY25 | 9 Aug 2024 | -5.2% | -3.7% | +21.2% | 1.9× |
| Q4 FY24 | 14 May 2024 | -2.9% | -3.3% | -1.0% | 2.8× |
| Q3 FY24 | 5 Feb 2024 | +1.9% | -7.7% | -8.3% | 0.9× |
| Q2 FY24 | 9 Nov 2023 | -0.6% | +7.9% | +17.9% | 3.1× |
| Q1 FY24 | 11 Aug 2023 | -0.3% | -4.0% | -3.5% | 2.5× |
| Q4 FY23 | 19 May 2023 | -3.8% | -4.6% | +1.9% | 2.6× |
| Q3 FY23 | 13 Feb 2023 | -1.3% | -2.0% | -8.2% | 1.1× |
| Q2 FY23 | 12 Nov 2022 | +4.7% | +2.9% | +4.3% | 8.3× |
| Q1 FY23 | 10 Aug 2022 | -3.2% | -3.2% | -1.2% | 3.5× |
| Q4 FY22 | 12 May 2022 | -9.0% | -6.6% | -6.3% | 1.3× |
| Q3 FY22 | 14 Feb 2022 | -3.0% | -15.5% | -12.8% | 0.8× |
| Q2 FY22 | 13 Nov 2021 | +0.7% | -7.2% | -5.4% | 2.2× |
| Q1 FY22 | 12 Aug 2021 | +1.0% | -14.1% | -7.2% | 3.0× |
| Q4 FY21 | 18 Jun 2021 | -1.2% | -0.2% | +9.8% | 0.3× |
| Q3 FY21 | 9 Feb 2021 | -4.5% | -8.6% | -9.2% | 2.9× |
| Q2 FY21 | 10 Nov 2020 | +2.9% | +2.6% | +12.6% | 3.3× |
| Q1 FY21 | 24 Aug 2020 | -8.6% | -17.2% | -16.6% | 1.7× |
| Q4 FY20 | 29 Jun 2020 | -11.8% | -14.5% | -18.4% | 4.9× |
| Q3 FY20 | 13 Feb 2020 | -5.1% | -12.1% | -36.0% | 1.2× |
| Q2 FY20 | 14 Nov 2019 | +2.9% | -2.8% | -6.2% | 20.5× |
| Q1 FY20 | 9 Aug 2019 | +2.1% | -4.3% | +1.3% | 6.9× |
| Q4 FY19 | 29 May 2019 | -7.0% | -12.9% | -19.1% | 3.0× |
| Q3 FY19 | 26 Feb 2019 | -1.5% | +9.2% | +1.8% | 0.5× |
| Q2 FY19 | 22 Nov 2018 | -2.3% | +1.2% | +4.9% | 1.3× |
| Q1 FY19 | 24 Aug 2018 | +1.0% | +29.8% | +10.6% | 0.3× |
| Q4 FY18 | 27 Jun 2018 | -3.4% | +4.9% | -6.5% | 0.9× |
| Q3 FY18 | 16 Mar 2018 | -1.3% | -2.7% | +0.6% | 0.4× |
| Q2 FY18 | 13 Dec 2017 | -0.9% | -1.4% | +32.4% | 1.2× |
| Q1 FY18 | 21 Sept 2017 | -0.3% | -5.4% | -0.3% | 0.5× |
| Q4 FY17 | 5 Jun 2017 | -1.4% | -3.2% | -5.0% | 0.9× |
| Q3 FY17 | 17 Feb 2017 | +0.3% | -0.9% | -7.9% | 0.2× |
| Q2 FY17 | 18 Nov 2016 | -0.4% | +2.9% | +7.3% | 0.3× |
| Q1 FY17 | 7 Sept 2016 | +1.7% | +1.1% | +5.0% | 0.3× |
| Average | -2.2% | -3.2% | -1.9% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +1.7% | +3.5% | +3.3% | +5.5% | +6.1% | +2.1% |
| Profit | -35.2% | -20.9% | -4.1% | -4.7% | +17.9% | -3.0% |
Key data
Delivery percentage
Over the last 20 sessions ALBERTDAVD settled 67.8% of its traded quantity, which is unusually high for an NSE equity. That is in line with its own one-year average of 68.2%. The latest session ranks higher than 94% of the 2,506 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.96% | -2.85% | -2.77% | -11.65% | +7.97% | -6.27% |
Valuation
Ownership
Quarterly results · standalone
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 89.9 | 85.9 | 101.3 | 100.8 |
| YoY chg | +8.2% | +14.6% | +43.6% | +15.6% |
| Net profit (₹ Cr) | 15.3 | (21.4) | 32.0 | 2.9 |
| YoY chg | — | — | +303.1% | — |
| Net margin | 17.0% | -25.0% | 31.6% | 2.9% |
| EPS | 26.81 | -37.56 | 56.07 | 5.05 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 62.24% · public 37.76%- Promoter
- Public and others
- Promoter
- 62.24%
- Public
- 37.76%
- Promoter change
- 0.00 pp
- Filed
- 12 Oct 2026
- FII
- 0.60%
- DII
- 1.64%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 0.01%
- Insurance
- 1.61%
- FPI
- 0.60%
- Retail ≤ ₹2L
- 25.56%
- HNI > ₹2L
- 2.36%
- NRI
- 0.90%
- Bodies corporate
- 1.96%
- Shareholders
- 12,709
0.00 pp QoQ
0.00 pp QoQ
+0.03 pp QoQ
+0.25 pp QoQ
-0.38 pp QoQ
-0.09 pp QoQ
+1.96 pp QoQ
-3.4% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| KOTHARI INVESTMENT AND INDUSTRIES PRIVATE LIMITED | Promoter · Corporate | 41.36% | 23.61L |
| ANAND VARDHAN KOTHARI | Promoter · Individual | 9.93% | 5.67L |
| M D KOTHARI AND COMPANY LIMITED | Promoter · Corporate | 6.92% | 3.95L |
| KOTHARI PHYTOCHEMICALS & INDUSTRIES LIMITED | Promoter · Corporate | 1.74% | 99.2K |
| ARUN KUMAR KOTHARI | Promoter · Individual | 1.70% | 97.0K |
| GENERAL INSURANCE CORPORATION OF INDIA | Insurance | 1.61% | 91.8K |
| VIKABH SECURITIES PVT. LTD. | Other | 1.00% | 57.3K |
| PRABHAWATI DEVI KOTHARI | Promoter · Individual | 0.31% | 17.5K |
| PARAMSUKHDAS SUGANCHAND HUF (KARTA - ARUN KUMAR KOTHARI) | Promoter · Individual | 0.26% | 15.0K |
| VEDIKA KOTHARI | Promoter · Individual | 0.03% | 1.5K |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹5.00 | ₹5.00 |
| FY2025-26 | 1 | ₹5.00 | ₹5.00 |
| FY2024-25 | 1 | ₹11.50 | ₹11.50 |
| FY2023-24 | 1 | ₹9.00 | ₹9.00 |
| FY2022-23 | 1 | ₹9.00 | ₹9.00 |
| FY2021-22 | 1 | ₹6.00 | ₹6.00 |
| FY2019-20 | 2 | ₹13.00 | ₹13.00 |
| FY2018-19 | 1 | ₹5.50 | ₹5.50 |
| FY2017-18 | 1 | ₹5.50 | ₹5.50 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 30 Jul 2026 | — | ₹5.00 | ₹5.00 |
| 25 Jul 2025 | — | ₹5.00 | ₹5.00 |
| 2 Aug 2024 | — | ₹11.50 | ₹11.50 |
| 3 Aug 2023 | — | ₹9.00 | ₹9.00 |
| 1 Aug 2022 | — | ₹9.00 | ₹9.00 |
| 6 Sept 2021 | — | ₹6.00 | ₹6.00 |
| 13 Mar 2020 | — | ₹7.00 | ₹7.00 |
| 1 Aug 2019 | — | ₹6.00 | ₹6.00 |
| 24 Aug 2018 | — | ₹5.50 | ₹5.50 |
| 1 Sept 2017 | — | ₹5.50 | ₹5.50 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 21 months ago
- Disclosures on record
- 43
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 27 Feb 2025 | KOTHARI PHYTOCHEMICALS & INDUSTRIES LIMITEDPromoter | Buy | 6.0K | ₹53.8L | 896.09 | 93.2K → 99.2K | 1.74%+0.11 pp | 7(2)told 25 Feb 2025 |
| 22 Mar 2024 | Kothari Phytochemicals & Industries LimitedPromoter | Buy | 2.7K | ₹29.5L | 1,091.36 | 90.5K → 93.2K | 1.63%+0.05 pp | 7(2)told 21 Mar 2024 |
| 22 Mar 2024 | Kothari Investment & Industries Private LimitedPromoter | Buy | 2.3K | ₹25.6L | 1,113.37 | 23.58L → 23.61L | 41.36%+0.04 pp | 7(2)told 20 Mar 2024 |
| 31 Mar 2023 | M D KOTHARI & COMPANY LTDPromoter | Buy | 1.0K | ₹5.2L | 520.32 | 3.94L → 3.95L | 6.92%+0.02 pp | 7(2)told 30 Mar 2023 |
| 18 Mar 2023 | KOTHARI INVESTMENT & INDUSTRIES PVT LTDPromoter | Buy | 2.0K | ₹10.6L | 529.66 | 23.56L → 23.58L | 41.32%+0.04 pp | 7(2)told 18 Mar 2023 |
| 17 Jun 2022 | ANAND VARDHAN KOTHARIDirector | Buy | 1.0K | ₹5.3L | 526.69 | 5.66L → 5.67L | 9.93%+0.02 pp | 7(2)told 15 Jun 2022 |
| 17 Jun 2022 | ARUN KUMAR KOTHARIDirector | Buy | 1.0K | ₹5.3L | 525.38 | 96.0K → 97.0K | 1.70%+0.02 pp | 7(2)told 15 Jun 2022 |
| 31 Mar 2022 | ARUN KUMAR KOTHARIPromoter | Buy | 1.0K | ₹5.4L | 535.96 | 95.0K → 96.0K | 1.68%+0.02 pp | 7(2)told 31 Mar 2022 |
| 23 Mar 2022 | ANAND VARDHAN KOTHARIPromoter | Buy | 1.5K | ₹8.3L | 552.91 | 5.64L → 5.66L | 9.91%+0.03 pp | 7(2)told 23 Mar 2022 |
| 23 Mar 2022 | ARUN KUMAR KOTHARIPromoter | Buy | 1.0K | ₹5.4L | 539.76 | 94.0K → 95.0K | 1.66%+0.02 pp | 7(2)told 22 Mar 2022 |
| 14 Mar 2022 | ARUN KUMAR KOTHARIPromoter | Buy | 3.0K | ₹15.6L | 521.11 | 91.0K → 94.0K | 1.65%+0.05 pp | 7(2)told 11 Mar 2022 |
| 7 Mar 2022 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 1.0K | ₹5.2L | 521.51 | 89.5K → 90.5K | 1.59%+0.02 pp | 7(2)told 4 Mar 2022 |
| 3 Mar 2022 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 4.1K | ₹22.0L | 536.06 | 85.4K → 89.5K | 1.57%+0.07 pp | 7(2)told 1 Mar 2022 |
| 27 Feb 2022 | ANAND VARDHAN KOTHARIPromoter | Buy | 1.5K | ₹8.2L | 549.60 | 5.63L → 5.64L | 9.88%+0.03 pp | 7(2)told 24 Feb 2022 |
| 27 Feb 2022 | ARUN KUMAR KOTHARIPromoter | Buy | 3.5K | ₹19.8L | 565.89 | 87.5K → 91.0K | 1.59%+0.06 pp | 7(2)told 24 Feb 2022 |
| 31 Dec 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 3.0K | ₹17.6L | 587.84 | 82.4K → 85.4K | 1.50%+0.05 pp | 7(2)told 29 Dec 2021 |
| 28 Dec 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 8.7K | ₹49.8L | 575.12 | 73.7K → 82.4K | 1.44%+0.15 pp | 7(2)told 21 Dec 2021 |
| 15 Dec 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 1.6K | ₹9.2L | 592.14 | 72.2K → 73.7K | 1.29%+0.03 pp | 7(2)told 14 Dec 2021 |
| 15 Dec 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 1.1K | ₹6.4L | 584.77 | 71.1K → 72.2K | 1.26%+0.02 pp | 7(2)told 3 Dec 2021 |
| 1 Dec 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 1.0K | ₹5.9L | 586.72 | 70.1K → 71.1K | 1.25%+0.02 pp | 7(2)told 25 Nov 2021 |
| 2 Oct 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 1.5K | ₹8.8L | 587.36 | 68.6K → 70.1K | 1.23%+0.03 pp | 7(2)told 30 Sept 2021 |
| 27 Sept 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 3.0K | ₹18.0L | 599.41 | 65.6K → 68.6K | 1.20%+0.05 pp | 7(2)told 24 Sept 2021 |
| 25 Aug 2021 | Kothari Phytochemicals and Industries LimitedPromoter | Buy | 4.0K | ₹23.2L | 580.20 | 61.6K → 65.6K | 1.15%+0.07 pp | 7(2)told 23 Aug 2021 |
| 31 Mar 2021 | ANAND VARDHAN KOTHARIPromoter | Buy | 500 | ₹1.9L | 378.82 | 5.62L → 5.63L | 9.86%+0.01 pp | 7(2)told 30 Mar 2021 |
| 26 Mar 2021 | KOTHARI INVESTMENT & INDUSTRIES PVT LTDPromoter | Buy | 1.2K | ₹4.7L | 382.59 | 23.55L → 23.56L | 41.29%+0.02 pp | 7(2)told 26 Mar 2021 |
| 24 Mar 2021 | ARUN KUMAR KOTHARIPromoter | Buy | 500 | ₹2.0L | 398.24 | 87.0K → 87.5K | 1.53%+0.01 pp | 7(2)told 22 Mar 2021 |
| 22 Mar 2021 | KOTHARI INVESTMENT & INDUSTRIES PVT LTDPromoter | Buy | 2.8K | ₹11.0L | 393.91 | 23.52L → 23.55L | 41.27%+0.05 pp | 7(2)told 20 Mar 2021 |
| 3 Jul 2020 | Prabhawati Devi KothariPromoter | Buy | 2.5K | ₹8.8L | 351.14 | 13.0K → 15.5K | 0.27%+0.04 pp | 7(2)told 16 Mar 2020 |
| 3 Jul 2020 | Vedika KothariRelative | Buy | 179 | ₹67,136 | 375.06 | 1.3K → 1.5K | 0.03%+0.00 pp | 7(2)told 16 Mar 2020 |
| 3 Jul 2020 | Vedika KothariRelative | Buy | 1.3K | ₹5.1L | 386.83 | — → 1.3K | 0.02% | 7(2)told 16 Mar 2020 |
| 3 Jul 2020 | Anand Vardhan KothariPromoter | Buy | 2.0K | ₹7.4L | 370.80 | 5.58L → 5.60L | 9.81%+0.04 pp | 7(2)told 16 Mar 2020 |
| 3 Jul 2020 | Anand Vardhan KothariPromoter | Buy | 500 | ₹2.1L | 415.01 | 5.58L → 5.58L | 9.78%+0.01 pp | 7(2)told 10 Jan 2020 |
| 3 Apr 2020 | Anand Vardhan KothariPromoter | Buy | 2.0K | ₹6.1L | 305.66 | 5.60L → 5.62L | 9.85%+0.04 pp | 7(2)told 1 Apr 2020 |
| 3 Apr 2020 | Prabhawati Devi KothariPromoter | Buy | 2.0K | ₹6.1L | 303.53 | 15.5K → 17.5K | 0.31%+0.04 pp | 7(2)told 1 Apr 2020 |
| 17 Mar 2020 | Anand Vardhan KothariPromoter | Buy | 0 | ₹7.4L | — | 5.58L → 5.58L | 9.81%0.00 pp | 7(2)told 16 Mar 2020 |
| 17 Mar 2020 | Prabhawati Devi KothariPromoter | Buy | 0 | ₹8.8L | — | 13.0K → 13.0K | 0.27%0.00 pp | 7(2)told 16 Mar 2020 |
| 9 Sept 2019 | PRABHAWATI DEVI KOTHARIPromoter | Buy | 527 | ₹1.8L | 332.90 | 12.5K → 13.0K | 0.23%+0.01 pp | 7(2)told 9 Sept 2019 |
| 28 Aug 2019 | ANAND VARDHAN KOTHARIPromoter | Buy | 1.0K | ₹3.3L | 331.31 | 5.57L → 5.58L | 9.77%+0.02 pp | 7(2)told 28 Aug 2019 |
| 21 Aug 2019 | ANAND VARDHAN KOTHARIPromoter | Buy | 1.5K | ₹5.4L | 362.11 | 5.55L → 5.57L | 9.75%+0.03 pp | 7(2)told 21 Aug 2019 |
| 17 Aug 2019 | ANAND VARDHAN KOTHARIPromoter | Buy | 300 | ₹1.1L | 383.29 | 5.55L → 5.55L | 9.72%+0.01 pp | 7(2)told 16 Aug 2019 |
| 17 Aug 2019 | ANAND VARDHAN KOTHARIPromoter | Buy | 1.2K | ₹4.6L | 380.67 | 5.54L → 5.55L | 9.72%+0.02 pp | 7(2)told 16 Aug 2019 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Bulk & block deals · 29 Aug 2024
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 29 Aug 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 29.0K | 1,652.20 | ₹4.8Cr |
| 29 Aug 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 29.0K | 1,649.18 | ₹4.8Cr |
| 26 Aug 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 32.5K | 1,553.72 | ₹5.1Cr |
| 26 Aug 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 32.5K | 1,551.82 | ₹5.0Cr |
| 23 Aug 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 31.0K | 1,409.57 | ₹4.4Cr |
| 23 Aug 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 31.0K | 1,403.65 | ₹4.3Cr |
| 23 Aug 2024 | Buy · bulk | PARAM CAPITAL | 30.0K | 1,445.60 | ₹4.3Cr |
| 25 Jan 2024 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 44.8K | 1,491.90 | ₹6.7Cr |
| 25 Jan 2024 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 44.8K | 1,487.46 | ₹6.7Cr |
| 3 Jan 2022 | Sell · bulk | XTX MARKETS LLP | 36.1K | 680.89 | ₹2.5Cr |
| 3 Jan 2022 | Buy · bulk | XTX MARKETS LLP | 35.5K | 680.42 | ₹2.4Cr |
| 18 Oct 2021 | Sell · bulk | SMP SECURITIES LTD | 92.3K | 633.81 | ₹5.9Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.
Exchange surveillance
- Under 100 traders in 30 days · since 28 Sept 2026 — Fewer than 100 distinct investors traded it in the last 30 days.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 88.3 | 89.1 | 89.4 | 98.4 | 83.1 | 74.9 | 70.6 | 87.2 | 89.9 | 85.9 | 101.3 | 100.8 | |
| Other income | 16.9 | 10.4 | 23.1 | 20.6 | (9.0) | (5.1) | 22.0 | (2.1) | 12.4 | (24.8) | 28.0 | (3.6) | |
| Total income | 105.2 | 99.5 | 112.4 | 119.1 | 74.1 | 69.8 | 92.6 | 85.1 | 102.3 | 61.0 | 129.3 | 97.2 | |
| Total expenses | 81.7 | 81.4 | 90.4 | 93.9 | 84.2 | 81.6 | 84.2 | 87.7 | 82.4 | 86.3 | 93.5 | 92.1 | |
| └ Finance costs | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.6 | 0.8 | 0.9 | 0.4 | 0.5 | 0.4 | |
| └ Depreciation | 1.7 | 1.8 | 1.8 | 1.7 | 1.7 | 1.8 | 2.4 | 2.2 | 2.4 | 2.7 | 2.3 | 2.5 | |
| Profit before tax | 23.4 | 18.1 | 22.1 | 25.1 | (10.2) | (11.8) | 8.4 | (2.6) | 19.9 | (25.2) | 35.8 | 5.1 | |
| Tax expense | 4.7 | 5.2 | 3.2 | 7.1 | (0.8) | (1.5) | 0.5 | 0.7 | 4.6 | (3.8) | 3.8 | 2.2 | |
| Net profit | 18.7 | 12.9 | 18.8 | 18.1 | (9.4) | (10.3) | 7.9 | (3.3) | 15.3 | (21.4) | 32.0 | 2.9 | |
| EPS | 32.80 | 22.63 | 33.02 | 31.67 | -16.45 | -18.10 | 13.91 | -5.79 | 26.81 | -37.56 | 56.07 | 5.05 | |
| Net margin | 21.20% | 14.50% | 21.09% | 18.36% | -11.30% | -13.79% | 11.25% | -3.78% | 17.02% | -24.96% | 31.58% | 2.86% | |
| PBT margin | 26.55% | 20.34% | 24.69% | 25.53% | -12.23% | -15.77% | 11.96% | -2.96% | 22.13% | -29.39% | 35.32% | 5.05% | |
| Tax rate | 20.13% | 28.72% | 14.59% | 28.10% | — | — | 5.93% | — | 23.11% | — | 10.61% | 43.41% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 12 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 423.4 | 454.5 | 498.0 | 535.3 | 511.4 | 532.9 | 519.1 | 553.5 | |
| Current assets | 303.4 | 324.1 | 371.6 | 416.1 | 354.0 | 397.1 | 374.4 | 411.8 | |
| └ Cash & equivalents | 1.4 | 4.8 | 5.4 | 3.7 | 0.4 | 0.9 | 0.3 | 3.4 | |
| └ Other bank balances | 23.8 | 12.2 | 25.7 | 35.8 | 1.3 | 24.3 | 32.5 | 29.2 | |
| └ Current investments | 166.8 | 205.8 | 254.3 | 277.5 | 242.2 | 259.1 | 225.1 | 255.1 | |
| └ Trade receivables | 30.3 | 32.5 | 29.3 | 34.6 | 27.4 | 41.6 | 33.9 | 47.8 | |
| └ Inventories | 50.7 | 39.8 | 43.6 | 47.5 | 63.9 | 51.5 | 58.3 | 53.3 | |
| Total equity | 311.6 | 350.3 | 383.0 | 413.2 | 392.5 | 393.9 | 391.5 | 421.9 | |
| └ Attributable to owners | 311.6 | 350.3 | 383.0 | 413.2 | 392.5 | 393.9 | 391.5 | 421.9 | |
| └ Share capital | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | |
| Borrowings | 5.3 | 0.9 | 2.1 | 3.5 | 10.0 | 41.4 | 28.5 | 33.9 | |
| └ Current | 4.7 | 0.6 | 2.1 | 3.0 | 10.0 | 40.5 | 28.5 | 33.0 | |
| └ Non-current | 0.6 | 0.3 | 0.0 | 0.6 | 0.0 | 0.9 | 0.0 | 0.9 | |
| Trade payables | 32.1 | 27.9 | 33.9 | 37.5 | 37.6 | 28.5 | 32.5 | 36.8 | |
| Current liabilities | 98.9 | 89.7 | 99.0 | 100.9 | 104.2 | 123.9 | 115.4 | 117.4 | |
| Total liabilities | 111.8 | 104.3 | 115.0 | 122.1 | 118.9 | 139.0 | 127.6 | 131.7 | |
| Net debt | (186.7) | (221.9) | (283.4) | (313.5) | (233.9) | (242.9) | (229.3) | (253.7) | |
| Debt / equity | 0.02 | 0.00 | 0.01 | 0.01 | 0.03 | 0.11 | 0.07 | 0.08 | |
| Current ratio | 3.07 | 3.61 | 3.75 | 4.12 | 3.40 | 3.20 | 3.24 | 3.51 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10.5 | 31.1 | 45.5 | (6.7) | (28.4) | (20.8) | (7.7) | 9.9 | |
| └ Capex | (5.2) | (6.0) | (10.9) | (10.3) | (14.9) | (6.3) | (29.1) | (8.2) | |
| Free cash flow | 5.3 | 25.0 | 34.6 | (17.0) | (43.3) | (27.1) | (36.8) | 1.7 | |
| Investing cash flow | (5.0) | (18.0) | (33.2) | 11.7 | 23.3 | (3.5) | (4.4) | (8.3) | |
| Financing cash flow | (6.4) | (9.8) | (8.3) | (6.8) | 0.1 | 24.9 | 11.9 | 1.5 | |
| └ Dividends paid | (5.1) | (5.2) | (5.2) | (6.5) | (0.2) | (2.8) | (2.9) | (2.9) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | (0.8) | 3.4 | 4.0 | (1.7) | (5.0) | 0.5 | (0.1) | 3.1 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →ALBERTDAVD at a glance
- ALBERTDAVD closed at ₹762.6 on 20 Nov 2026, +0.96% on the day, -6.3% over one year, 18.2% below its 52-week high of ₹931.85.
- Delivery was 87.6% of traded quantity on 20 Nov 2026, the 94th percentile of its own 2,506 sessions with a reading (20-session average 67.8%, 1-year average 68.2%).
- Market capitalisation is ₹435 crore at a trailing P/E of 15.1 (trailing EPS ₹50.37).
- Q2 FY27 results (standalone, filed 12 Nov 2026): revenue ₹101 crore (+15.6% year on year), net profit ₹3 crore; the price moved -3.2% on the first session after.
- Promoters held 62.24% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 5 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE